Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/ or pathological angiogenesis or neovascularization

Details for Australian Patent Application No. 2008219216 (hide)

Owner Ablynx N.V.

Inventors Merchiers, Pascal Gerard; Verheesen, Peter; Hoogenboom, Hendricus Renerus Jacobus Mattheus

Agent Shelston IP

Pub. Number AU-A-2008219216

PCT Pub. Number WO2008/101985

Priority 61/015,957 21.12.07 US; 60/902,532 21.02.07 US

Filing date 21 February 2008

Wipo publication date 28 August 2008

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

30 July 2009 PCT application entered the National Phase

  PCT publication WO2008/101985 Priority application(s): WO2008/101985

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008219226-Indole derivatives

2008219204-Active material diffuser and method of providing and using same